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INTRODUCTION
 LIFE THREATENING REFRACTORY ASTHMA:
•  Requires intubation and mechanical ventilation
•  Often presents with high level of arterial PaCO2 which 
require both a high minute ventilation and airway 
pressures despite lung protective ventilation and the 
administration of Heliox gas mixture
•  Ventilator induced trauma (VILI) is common
•  Has a mortality rate of around eight percent
INTERVENTION
•  Another approach to meet gas 
exchange goals and to provide 
maximum lung protective is to 
place these patients on venous-
venous extracorporeal  
membrane oxygenation  
(ECMO) support.  
•  The clinical rational for this 
management would be to protect  
the lung from any additional VILI  
and provide a stable level of 
ventilation and acid-base balance.
•  Allows for other clinical interventions to be 
administered in a more systematic manner. 
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METHODS
•  During a two year time frame, we placed six status 
asthmaticus patients with refractory gas exchange on 
V-V ECMO. 
•  Five of the six patients were managed on  V-V ECMO 
until the asthma exacerbation was stabilized and 
progressed to ECMO and ventilator liberation. 
•  One patient expired secondary to multi-system organ 
failure unrelated to asthma. 
•  All patients were ventilated via pressure or volume 
target modes to achieve an exhaled tidal volume 
between 4-5cc/kg/IBW and PEEP was set via either a 
pressure/volume tool or via transpulmonary monitoring. 
•  ECMO parameters were set to achieve a SpO2>88% 
and a PH>7.25. There was no additional occurrences 
of VILI post ECMO intervention. 
•  All patients receive pharmacological paralytics, heliox, 
and continuous beta-agonist therapy for the first forty 














1 51/M S PCMV 4cc/kg 7 100/51pm 120 hrs. Y
2 28/M S CMV 4cc/kg 8 100/91pm 70 hrs. Y
3 49/M S PCMV 5cc/kg 5 100/4.51 pm 42 hrs. Y
4 31/F E CMV 5cc/kg 15 80/31 pm NA Y
5 18/M S CMV 4cc/kg 8 80/41 pm 209 hrs. Y
6 31/F S PCMV  4cc/kg/IBW 9 100/1.51 pm 42 hrs. Y
All received continuous Proventil nebulization
PEEP settings were guided by transpulmonary E-2 to 2cm
PEEP range 10–16cm
Patients 4 and 5 developed barotrauma prior to cannulation
CONCLUSION
BASED ON OUR CLINICAL EXPERIENCES:
•  V-V ECMO along with lung protective ventilation can 
provide a safe, clinical management of the status 
asthmaticus with refractory gas exchange. 
•  Lower minute ventilation and airway pressures can be 
achieved minimizing the risk of VILI.
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